Seed VC · Amsterdam
Check size: $2.4M to $24.1M
EQT Life Sciences targets innovative companies focusing on therapeutics, medical devices, diagnostics and healthtech, aiming to transform cutting-edge scientific innovation into impactful healthcare solutions that address unmet clinical needs while delivering superior returns for investors.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Researchers, Healthcare providers, Patients
Geography
Europe, US, Global
+ 1 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Life Sciences Partners writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Life Sciences Partners alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Life Sciences Partners is one of them, and we'll tell you exactly where they sit in your top 100.